1-855-378-42281-855-378-4228
One of the out-patient treatment options for people in Shenandoah Junction who are battling with opioid dependence and addiction is called opioid maintenance therapy. Licensed centers and doctors are authorized to administer specific meds to opioid dependent individuals, many of which are opioid-based also and are habit forming. In low enough amounts the user doesn't experience high feelings and also does not experience acute cravings and is not experiencing opioid withdrawal. Methadone is the first med tried for this sole purpose, but there are alternative choices currently to select from.
Methadone is an opiate and can be taken at an out-patient clinic licensed to administer the drug, which is taken on a daily basis in liquid or pill form. The cost of the med is around $150 monthly. Buprenorphine is also an opiate based drug, and is a pill often taken one day on, one day off. But unlike Methadone that is only be dispensed in well-regulated clinics, Buprenorphine can be and is prescribed and administered in doctor's offices. The monthly cost of buprenorphine is around just under $300 /month for the generic of the med. There is also a version of buprenorphine that contains the ingredient naloxone, which is a med that blocks the effects of opiates. A person taking this version of the drug, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs about $450 monthly. Naltrexone is another med used in opioid maintenance therapy, but unlike the other medications aforementioned it is an opiate blocker and isn't an opiate. There is an option to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, the drug prevents someone from experience being high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 per month.
For All Drug and Alcohol Treatment Programs In Shenandoah Junction, Click Here.
